retatrutide triple agonist clinical trials Retatrutide, an experimental drug currently in Phase 3 trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a hormone There's a new name in

A coronavirus and IBD reporting database on Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) has shown a cluster of outcomes for IBD patients diagnosed with COVID-19

90% saw hair improvement in 2 months After consistent use for 8 weeks, the majority of participants reported stronger, healthier-looking hair with reduced breakage and improved shine

[3] Prolonged therapy can unmask or exacerbate benign prostatic hyperplasia, raise prostate-specific antigen, worsen untreated obstructive sleep apnoea and is associated in some observational studies with a small but controversial increase in cardiovascular events, underlining the necessity for baseline and periodic monitoring of PSA, lipids and cardiovascular risk factors

[DOI] [PMC free article] [PubMed] [Google Scholar] 183.Aborode A.T., Pustake M., Awuah W.A., Alwerdani M., Shah P., Yarlagadda R., Ahmad S., Silva Correia I.F., Chandra A., Nansubuga E.P., et al